TCT-745 Early results of Revivent Procedure in the Treatment of Patients with Left Ventricular Dilatation and Heart Failure due to Ischemic Cardiomyopathy

For patients with heart failure (HF) due to ischemic cardiomyopathy (ICM), reconstruction and volume reduction of the scarred left ventricle (LV) may be beneficial. The Revivent “Less Invasive Ventricular Enhancement” procedure (BioVentrix, Inc, San Ramon, CA) , is a minimally invasive method